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INTRODUCTION
Over 50,000 women are diagnosed with breast cancer 
annually in the United Kingdom, 30–40% require mastecto-
my.1,2 Advances in breast cancer diagnosis and management 
have produced significant improvements in breast cancer–
related survival. Over 60% of women who had breast cancer 
survive for 20 years following initial diagnosis.3,4 Therefore, 
there is an increased need to recognize quality of life and 
quality of care in this population. Clinicians need to con-
sider patient perceptions of the delivery of care and results 
of surgery in addition to patient morbidity and mortality. 
Measuring patient-reported outcomes (PROs) has become 
increasingly important in cancer care.5 Patients’ satisfaction 
with their surgical outcome alongside postsurgery quality of 
life and psychosocial wellbeing is vitally important for wom-
en undergoing breast oncoplastic surgery. Indeed PROs 
are increasingly important to the modern model of breast 
cancer management with potential for greatly enhanced 
quality of care, reflecting the change of focus from the phy-
sician’s to the patient’s perspective. It is suggested that the 
use of valid, reliable, and clinically useful patient-reported 
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Background: Since BREAST-Q was developed in 2009, it has been widely used by 
clinicians and researchers to capture information regarding health-related qual-
ity of life (HRQoL) and patient satisfaction related to breast surgery. Yet clinical 
guidelines regarding the use of BREAST-Q for assessment of success of surgery 
in women with breast cancer remain limited. To maximize the benefits of using 
BREAST-Q to inform clinical decision making, this systematic review aimed to iden-
tify and appraise current evidence on patient-reported outcomes (PROs)  assessed 
by BREAST-Q associated with breast oncoplastic surgery.
Methods: A detailed search strategy was implemented and electronic databases 
searched include PubMed, MEDLINE, CINAHL, and PsycINFO. Review was lim-
ited to peer-reviewed studies published in English from 2009 to January 2018. Any 
interventional and observational studies that used BREAST-Q to assess PROs in the 
assessment of breast oncoplastic surgery were included.
Results: Fifty-four peer-reviewed articles met inclusion criteria. Fifty-three studies 
were observational, 1 study was interventional. Current comparative studies using 
BREAST-Q indicated that abdominal flap, buttock flap, or thigh flap reconstruc-
tion offered highest satisfaction with breast; contralateral prophylactic mastectomy 
with immediate reconstruction offered higher levels of satisfaction with breast, but 
poor postsurgical physical well-being. Silicone implant and no radiation therapy 
offered higher level satisfaction and HRQoL.
Conclusions: Current evidence showed that BREAST-Q can effectively measure pa-
tient’s satisfaction and HRQoL in relation to different type of breast oncoplastic 
surgeries. BREAST-Q captured meaningful and reliable information from the pa-
tients’ perspective and may be useful for clinical decision making. (Plast Reconstr 
Surg Glob Open 2018;6:e1904; doi: 10.1097/GOX.0000000000001904; Published online 
7 August 2018.)
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outcome measures (PROM’s) should have an increased 
role in decision making.6,7
For instance, Pusic et al.8 conducted a systematic review 
of PRO instruments for measuring health-related quality of 
life (HRQoL) following cosmetic and reconstructive breast 
surgery. They found that only 1 breast-related symptoms 
questionnaire demonstrated adequate development and 
validation in its target population. Furthermore, that ques-
tionnaire focusing on measuring breast symptoms only had 
significant content limitations.8 Pusic et al.8 concluded that 
a new validated cosmetic and reconstructive breast surgery–
specific instrument was needed to determine the benefits 
of breast surgery. Subsequently, Pusic et al.9 developed a 
conceptual framework, BREAST-Q, drawing on patient 
interviews, focus groups, expert panels, and a literature 
review. BREAST-Q measures patients’ perceptions both 
quantitatively and qualitatively by examining 3 quality of 
life domains (psychosocial well-being, physical well-being, 
and sexual well-being) and 3 satisfaction domains (satisfac-
tion with breasts, satisfaction with outcome, and satisfac-
tion with care).9 BREAST-Q is free of charge for nonprofit 
academic research and in clinical care. Since its inception, 
BREAST-Q has been translated into 30 languages and wide-
ly used by clinicians to gain insights into the effectiveness of 
breast cosmetic and therapeutic surgeries. Recently, Cohen 
et al.10 carried out a scoping review on the use of BREAST-Q 
in surgical research, analyzing peer-reviewed articles pub-
lished between 2009 and 2015 including breast cosmetic 
(augmentation or reduction) and therapeutic surgeries. 
They aimed to provide plastic surgeons with general over-
views on the use of BREAST-Q from a clinical perspective. 
The authors made some generalized observations of how 
BREAST-Q has increased the use of PROMs in breast sur-
gery. Yet, there was no specific research question addressed 
by that review. They found the level of satisfaction and qual-
ity of life or stress triggers in women undergoing breast on-
cological surgeries can be different from women who seek 
cosmetic breast surgeries. Although the use of PROMs has 
increased, it is unclear to what extent BREAST-Q has been 
used to assess satisfaction and quality of life associated with 
breast oncoplastic surgery. Clinical practice guidelines re-
garding the use of BREAST-Q for assessment of the success 
of surgery in women with breast cancer remain limited. 
To maximize the benefits of using BREAST-Q to inform 
clinical decision making, overall aim of this review was to 
critically appraise and synthesize the research evidence 
available on PROMs assessed by BREAST-Q associated with 
breast surgery in women who had breast cancer. This review 
therefore sought to address 4 specific questions:
 1) To what extent has BREAST-Q been used to evaluate 
satisfaction and HRQoL among patients undergoing 
surgery for breast cancer?
 2) Which types of oncoplastic surgical procedures have 
been studied for PROs using BREAST-Q question-
naire in women who had breast cancer?
 3) What are the outcome parameters of BREAST-Q used 
in the literature?
 4) How clinically effective is BREAST-Q as a tool for mea-
suring PROMs in oncoplastic breast surgery?
METHODS
Identification of Studies
A systematic review protocol for the identification, re-
trieval, and appraisal of the evidence was first developed 
in June 2016 and updated in June 2017.11 The final search 
was carried out on January 15, 2018. We searched all rel-
evant literature published from 2009 to January 15, 2018 
in 4 databases, without any language restrictions. We used 
free-text, key word, and Medical Subject Headings terms 
for each of the following databases: PubMed, MEDLINE, 
CINAHL, and PsycINFO. We entered subject subheadings 
and word truncations according to database requirements 
to map all possible key word terms. Search terms included
 • Search terms for breast cancer: breast cancer or mam-
mary cancer
 • Search terms for breast oncology surgery: breast surgery, 
lumpectomy, breast conservation, breast conserving sur-
gery, mastectomy, breast reconstruction, questionnaires
 • Search terms for quality of life and patient satisfaction 
measurement tool: BREAST-Q. QoL, HRQoL, outcome 
assessment, outcomes and process assessment, patient 
reported outcome, health status, and satisfaction.
We also searched the NICE, Scottish Intercollegiate 
Guidelines Network. Additionally, we checked reference 
lists of included studies and other relevant review papers 
for further eligible studies.
Inclusion Criteria
To capture all relevant evidence, eligible studies in-
cluded experimental studies (randomized controlled 
trials, nonrandomized controlled trial, and pre- and post-
studies) and observational studies (cohort studies, case se-
ries, case control studies). Further study inclusion criteria 
were applied as follows:
 • Primary research studies published in peer-reviewed 
journals;
 • Studies with a target population including women with 
primary breast cancer irrespective of their age, type, 
and stage of cancer, that is, invasive or in situ;
 • Studies comparing any type of oncoplastic breast sur-
gery, for example, breast conservative surgery, mastec-
tomy with/without any type of reconstruction;
 • Studies reporting outcomes using BREAST-Q question-
naires developed by Pusic et al (2009).9
We excluded literature reviews, book chapters, conference 
proceedings, dissertations/thesis, letters or editorial opin-
ions, and non-English articles. We also excluded if target 
populations were patients who did not have breast cancer. 
Types of studies excluded were case reports or any study 
without comparison of oncological breast therapies. Stud-
ies that did not use BREAST-Q questionnaire or did not 
fully report BREAST-Q satisfaction or HRQoL outcomes 
were also excluded.
Data Extraction and Analysis
A data extraction form of common tables was de-
signed and piloted in line with the aim and objectives 
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of this  review. The following data were extracted from 
eligible articles by 1 reviewer (L. Q. L.) and verified by 
a second reviewer (S. M.) to ensure accuracy: year of 
publication, country of author affiliated, sample size, 
participants’ age, the type of oncological surgery, fol-
low-up period, outcomes measured by BREAST-Q and 
findings.
Unlike experimental studies, there are no validated 
assessment tools to assess the quality of observational 
studies so far. As most of the articles in our review were 
observational, each reviewer independently reported on 
the following: role of the investigator (ie, interventional 
versus observational study), overall study design (pro-
spective, retrospective, or cross-sectional), type of study 
(ie, randomized or nonrandomized clinical trial, survey, 
case series, etc.). Studies were graded using a hierarchy of 
evidence, based on the modified Oxford Centre for Evi-
dence-Based Medicine 2011 “Levels of Evidence and Clini-
cal Guidance Outcomes group”12 like Harding et al.13 and 
Clucas et al.14 A detailed grading scale is summarized (see 
appendix, Supplemental Digital Content 1, which displays 
Grading criteria for primary studies, http://links.lww.com/
PRSGO/A833).
Any disparity in either selecting eligible articles or 
assessed findings between the 2 independent reviewers 
was resolved through consultation with a third reviewer 
(O. A. B).
RESULTS
Included Studies
The literature search identified a total of 985 unique 
references of which 54 studies met the inclusion criteria 
for full data extraction (Fig. 1). All 54 articles identified 
their target population as patients with primary breast 
cancer (invasive or in situ), with sample sizes ranging 
from 13 to 7,619. Figure 2 shows the frequency of stud-
ies conducted across 11 countries. Nine studies did not 
report the follow-up duration at the time of complet-
ing BREAST-Q questionnaire. Figure 3 demonstrates 
the mean follow-up duration in those 45 studies re-
ported the follow-up duration. The characteristics of 
all 54 studies are summarized in Supplemental Digital 
 Content 1.
Grade of Evidence
Out of 54 studies included in this review, 53 were 
observational studies, 1 study was experimental. Four-
teen studies were classified as grade II, 12 were grade 
IIA (by reporting adjusted confounding factors, having 
a follow-up of more than 75% and key characteristics 
matched between comparison groups). The majority 
of the studies (34 of 54) were classified as grade III. 
The remaining 6 studies were rated as grade IV (weak 
 evidence).
Fig. 1. a flowchart of the selection process for articles.
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BREAST-Q Modules
The BREAST-Q tool consists of different modules to mea-
sure patients reported outcomes following surgery. There 
are breast cancer–specific modules (mastectomy, reconstruc-
tion, and breast conserving-therapy), in addition to modules 
for noncancer surgery (breast reduction/mastopexy, breast 
augmentation). The modules and individual domains of the 
BREAST-Q questionnaire were selected by authors with di-
verse aims described across the 54 studies reviewed. The use 
of different outcome domains together with varied breast 
oncological therapy/procedures and different study designs 
limits the comparability of results across different samples. 
This inevitably prevented meta-analysis of the data.
All 54 studies aimed to assess satisfaction and/or 
quality of life after breast oncological therapy. Figure 4 
demonstrates how the questionnaire was distributed. All 
the studies used the reconstruction module to measure 
patient-reported outcomes, with 3 studies comparing mas-
terectomy alone versus mastectomy plus reconstruction. 
Therefore, mastectomy module was used for patients who 
had mastectomy alone in those 3 studies (see appendix, 
Supplemental Digital Content 2, articles 3, 10, and 16, 
which displays characteristics of all 54 articles included 
in this review, http://links.lww.com/PRSGO/A834). About 
3 quarters of the studies (37 of 54) assessed postsurgery 
outcomes alone, 17 studies reported both pre- and post-
Fig. 2. number of studies conducted across 11 countries.
Fig. 3. Mean duration of follow-up in 45 studies.
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surgery outcomes, and 2 studies reported presurgery out-
comes only.
Although all studies measured satisfaction and/
or quality of life, 5 reported satisfaction outcomes only 
(Supplemental Digital Content 2 articles 2, 6, 13, 25, and 
40), and 3 reported on the quality of life domain alone 
(Supplemental Digital Content 2 articles 20, 26, and 27) 
35,41,42 All other 46 studies reported both satisfaction and 
HRQoL domains. Satisfaction with breast was measured 
in all 54 studies. Other satisfaction domains such as satis-
faction with care, that is, surgery outcome, medical staff, 
surgeon, information, and office staff were selectively re-
ported by individual studies.
BREAST-Q Response Rate
Thirty-eight studies reported a response rate for com-
pletion of the BREAST-Q, which ranged from 32% to 100% 
(Fig. 5). One study noted a lower response rate in response 
to the sexual well-being domain in comparison with other 
domains (Supplemental Digital Content 2 article 13).
Comparison of Models for Breast Cancer Treatment
A broad range of oncoplastic surgical procedures were 
described by individual studies. All 54 studies described 
comparisons of different breast cancer treatments/ surgical 
procedures. Comparisons included conservative surgery 
versus mastectomy with reconstruction versus mastectomy 
only; mastectomy with immediate reconstruction versus 
delayed reconstruction; symmetrization procedures versus 
no/delayed symmetrization; nipple-sparing mastectomy 
versus skin-sparing mastectomy; autologous grafting ver-
sus implant reconstruction; silicone versus saline implant, 
shaped gel versus round gel implant, radiation therapy 
versus no radiation therapy, comparison among different 
type of reconstruction procedures, that is, tissue expand-
er/implant, direct to implant, microsurgical flaps (trans-
verse rectus abdominis myocutaneous, muscle-sparing 
transverse rectus abdominis myocutaneous, deep inferior 
epigastric artery perforator, superficial inferior epigastric 
artery, superior gluteal artery perforator, and inferior glu-
teal artery perforator, and pedicled transverse rectus ab-
dominis myocutaneous flaps (and lat dorsi).
Patient-reported Outcomes as Measured by BREAST-Q
Satisfaction and HRQoL Domains
Table 1 draw together a summary of comparative as-
sessments of satisfaction with the breast and HRQoL af-
ter different breast oncological therapies, as reported in 
those studies within this review. Given that the comparison 
mode varied greatly across individual studies, the data in 
Table 1 may give indications, rather than definitive guides 
for clinical decisions.
DISCUSSION
Since BREAST-Q was developed in 2009, it has been 
used extensively to assess the impact of oncoplastic treat-
ment on PROs in breast surgery. PROMs questionnaires 
need to demonstrate reliability (ability to produce consis-
tent and reproducible scores) and validity (ability to mea-
sure what is intended to be measured). Satisfying these 
requirements, the BREAST-Q has become the gold stan-
dard PROMs instrument for breast surgery.
Fig. 4. Frequency of distribution method of BreaSt Q 
 questionnaires.
Fig. 5. response rate of BreaSt-Q questionnaire.
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The value of BREAST-Q is that clinicians now have 
data, with regard to patient satisfaction and HRQoL, 
which can be drawn upon to support patients in making 
decisions about best options for oncoplastic breast sur-
gery. However, although results presented here give an 
indication of what might offer the best outcomes from a 
patient perspective, conclusions on PROs associated with 
breast oncological surgery should be interpreted with cau-
tion. Nearly all studies included in this review were obser-
vational studies with a small number of prospective and 
longitudinal in design, which meant the majority were 
classified as level III evidence. Different oncoplastic proce-
dures alongside differences in study design and outcome 
reporting prevented a meta-analysis. This is not a criticism 
of the BREAST-Q, which has provided a fully validated 
patient-centered objective outcome measure, but a reflec-
tion on the fact that only 2.2% of plastic surgery articles 
are level I evidence.15 Given the nature of outcomes re-
search in this population, it is recognized that the use of 
an interventional study design would be challenging and 
perhaps unethical or unfeasible. Lower levels of evidence 
can address some subtleties of surgical technique valuable 
to the practicing surgeon but not currently amenable to 
prospective, controlled, randomized trials.16
The BREAST-Q has been used as a national out-
come measure in the National Mastectomy and Breast 
Table 1.  Summary of Satisfaction and HR-QoL Findings Using BREAST-Q
Higher Levels of Satisfaction Compared with Lower Levels of Satisfaction
Abdominal flap, buttock flap or thigh flap  
reconstruction
Mastectomy alone or breast-conservation surgery
Breast conservation surgery Implant reconstruction or mastectomy without 
reconstruction
Immediate reconstruction (but these patients were less 
satisfied with their plastic surgeons and had lower 
scores of physical wellbeing at 1 week postsurgery)
Delayed reconstruction
Successful breast reconstruction—significantly more 
satisfied with appearance of breast
Mastectomy alone
Contralateral prophylactic mastectomy Non-CPM
Microsurgical abdominal flap breast reconstruction Expander-implant breast reconstruction
PTRAM, DIEP, and SIEA reconstructive surgery—less 
severe postoperative pain
Tissue expander/implant reconstruction
Silicone implant but no difference between shaped 
versus round cohesive gel
Saline implant
No radiation therapy Radiation therapy—significantly lower satisfaction 
with breasts
Higher Levels of HR-QoL Compared with Lower Levels of HR-QoL
Unilateral mastectomy with reconstruction—signifi-
cantly higher scores for physical well-being of the 
chest
Contralateral prophylactic mastectomy and recon-
struction
Immediate reconstruction—higher score of psychoso-
cial and sexual well-being
Delayed reconstruction
Successful breast reconstruction—significantly better 
psychosocially and sexually
Mastectomy alone
Mastectomy with/without reconstruction Breast conservation—significantly lower scores in 
physical wellbeing of the chest, sexual well-being 
for total mastectomy with reconstruction, but sig-
nificantly higher scores in sexual well-being scores 
than total mastectomy without reconstruction
Microsurgical abdominal flap breast reconstruction—
higher scores in psychosocial and sexual wellbeing
Staged expander-implant breast reconstruction
Silicone implant recipients—higher scores in psycho-
logical well-being, sexual well-being
Recipients of saline implants
Mastectomy with immediate autogenous tissue recon-
struction—highest physical well-being score
Immediate postmastectomy implant 
 reconstruction
No radiation therapy Radiation therapy—significantly lower psychoso-
cial well-being, sexual well-being, and physical 
well-being
DIEP, deep inferior epigastric artery perforator; SIEA, superficial inferior epigastric artery.
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 Reconstruction Audits in the United Kingdom (over 8,000 
women between 3 and 18 months after surgery, with an 85% 
response rate),17 and the Army Of Women Study (over 7,600 
women with a mean of 6.7 years since surgery and an 82% 
response rate) in the United States.18 It has also been used in 
the assessment of the surgical treatment of early stage breast 
cancer at a national level in the National Cancer database 
of the American College of Surgeons.19 Capturing PROMs 
data are recommended as a standard of care by our repre-
sentative national bodies the Association of Breast Surgeons, 
the British Association of Plastic Reconstructive & Aesthetic 
Surgeons and the Royal College of Surgeons in the United 
Kingdom, and the American Society of Plastic Surgeons in-
ternationally. In addition, the BREAST-Q Satisfaction with 
Breasts scales is recommended in the International Consor-
tium for Health Outcomes Measurement (ICHOM) stan-
dard order set for breast cancer patients.20
Traditionally, outcomes in oncoplastic breast surgery 
have been centered on the provider’s perspective, focus-
ing on measuring complications and considering photo-
graphic analyses/panel assessments. Today, however, this 
is no longer sufficient to support progress being made in 
the field. In the current environment of the health care 
industry restrictions and performance metrics, quality-of-
life outcomes are ever more important in clinical practice, 
research, and health care funding.
Perhaps the most useful setting of the BREAST-Q is 
in longitudinal studies. A single measurement provides 
little information as the results of surgical intervention 
change over time. Satisfaction with appearance between 
expander/implant reconstruction may be similar up to 
3 years postoperatively, but the disparity with autologous 
reconstruction increases continuously with time, with free 
flap-based reconstruction being superior with regard to 
long-term outcome.21
Data on outcome measures within these studies should 
be used as a baseline, with outcomes from further prospec-
tive studies using BREAST-Q being used to strengthen 
evidence on best approaches to oncoplastic breast surgery. 
Future research is recommended and needed in the form of 
well-designed prospective longitudinal multicenter cohort 
or clinical interventional studies in large populations to 
determine the effectiveness of specific breast surgery types. 
Findings would further improve clinician decision making 
on which type of breast surgery should be advocated and 
adopted to enhance HRQoL and patients’ satisfaction.
It is worth noting that among the 54 articles included 
in this review, 10 were subanalyses of the Mastectomy Re-
construction Outcomes Consortium (MROC) Study. The 
MROC is a multicenter study involving 57 plastic surgeons 
at 11 academic and private practice sites across the United 
States and Canada. The primary aim of the MROC Study 
was to compare patient outcomes among the common 
surgical options for breast reconstruction. BREAST-Q was 
given to patients before reconstruction surgery. So far, 
2-year outcomes have been partially reported (Supple-
mental Digital Content 2 articles 28 and 52) A full analysis 
of MROC with longer term follow-up data will provide an 
important insight for the effectiveness of different surgical 
procedures on PROMs.
The key to the success in the surgical care of breast can-
cer patients is to make PROMs assessment a standard of 
care, to be completed before and after surgery at intervals, 
and to ensure a high questionnaire completion rate, essen-
tial to any high-quality study. An unpublished interim analy-
sis of iBRA national practice suggests that only 7–13% of 
U.K. units are collecting PROMs prospectively. This is large-
ly due to the current system being paper-based, manpower-
dependent, and too labor-intensive to integrate into daily 
practice. As the world becomes increasingly digitized, use of 
electronic, emailed versions of the questionnaire, or com-
pleted via an App are likely to improve completion rates. 
It is on this basis, and in combination with well-designed 
high-level studies, that we will be able to use such data to 
make patient-centered, objective assessments of what is 
in the patient’s best interests, which will support fully in-
formed shared decision making. Such implementation will 
give real-time updates on how patients feel, provide quality 
assurance, facilitate clinical decision making and evaluation 
of new treatments, provide surgeon feedback, audit data, 
and support health care funding based on quality of life.
Study Limitations
Although systematic reviews have their own merit 
for increasing the statistical power of the existing small 
sample size of individual studies, they often present limi-
tations. These include publication bias, language restric-
tions, heterogeneity across studies, and coding of key 
words. However, we adopted a well-structured search strat-
egy, supplemented all “explode” functions and utilized 
hand searches and contacted breast surgical specialists to 
minimize the potential bias.
Another limitation is that the substantial heterogeneity 
in oncoplastic procedures alongside a variety of selected 
PROMs domains prevented us from performing a pooled 
analysis. Nevertheless, the aim and objectives of this cur-
rent systematic review was to identify the updated evi-
dence, and to make recommendations for future research 
implementing BREAST-Q for better management of the 
breast cancer population.
CONCLUSIONS
Current evidence showed that BREAST-Q can effectively 
measure patient’s satisfaction and HRQoL in relation to dif-
ferent type of breast oncoplastic surgeries. BREAST-Q may 
be used as a tool to help clinicians and patients to make a de-
cision on which breast surgery should be advocated and ad-
opted to enhance HRQoL and patients’ satisfaction. Future 
more well-designed prospective multicenter cohort studies 
with longitudinal design using large sample populations or 
clinical interventional studies if feasible will provide further 
insight on the clinical application of BREAST-Q.
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